Silicon dioxide (silica) is a mineral ingredient widely used in cosmetics for its absorbent, texturizing, and exfoliating properties. However, its safety depends on its form, particle size, and route of exposure, warranting a rigorous risk assessment. Discover more about these risks.

- Carnet
- Active Ingredients
- Are there any risks associated with the cosmetic use of silica?
Are there any risks associated with the cosmetic use of silica?
- An essential distinction: amorphous silica vs crystalline silica
- Silica Nanoparticles: A Hazard in Cosmetics?
- Inhalation of fine particles: the primary identified risk associated with silica
- Silica: skin tolerance and dermatological profile
- Environmental impact: silica, a sustainable alternative
- Sources
An essential distinction: amorphous silica vs crystalline silica.
Silicon dioxide, also known as silica (silica), is a mineral-derived ingredient commonly used in cosmetic products. It primarily functions as an absorbent, mattifying, texturizing, or exfoliant. Although it is widely included in skincare and makeup formulations, questions remain about its safety, particularly regarding its physico-chemical form, particle size, and route of exposure.
The silica exists in two main forms: amorphous and crystalline. The amorphous silica, used in cosmetics, can be natural or synthetic. It is characterized by low water solubility, chemical inertness, and an absence of an ordered crystalline structure. Toxicological evaluations, notably those by the Cosmetic Ingredient Review (CIR) and the Scientific Committee on Consumer Safety (SCCS), conclude that it is safe for topical application under normal use conditions.
In contrast, the crystalline silica, classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC), is toxic when inhaled chronically, particularly in occupational settings.
This form is neither used nor authorized in cosmetic products due to its demonstrated risk.
Silica Nanoparticles: A Hazard in Cosmetics?
The introduction of silica nanoparticles in certain cosmetic formulations (particles <100 nm) has prompted increased scrutiny from regulatory authorities. The SCCS recommends a case-by-case assessment focusing on structure, surface, solubility, and bioavailability. Available data suggest that cutaneous penetration of nanoscale silica is very low to nonexistent on intact skin. However, if the skin barrier is compromised, permeability could theoretically increase. European regulations require that silica nanoparticles be surface-modified, insoluble and not present in products intended for inhalation, such as sprays or aerosols. To date, no systemic toxic effects have been demonstrated in vivo under normal cosmetic use conditions.
Inhalation of fine particles: the primary identified risk associated with silica.
The primary risk associated with cosmetic silica involves theinhalation of particles, particularly in loose powders (foundation powders, finishing powders) or spray products. Even in its amorphous form, silica in suspension can cause upper respiratory tract irritation after prolonged or repeated exposure. This risk is increased if the particle size is below 10 µm, allowing them to reach the pulmonary alveoli.
Inhalation of fine particles of silica, present in certain cosmetic products in the amorphous or crystalline, can lead to pulmonary inflammatory reactions and health risks. Studies show that the toxicity of silica depends on the surface structure of the particles. Among these surface features, the 'quasi-free' silanol groups play an important role. These small chemical moieties (≡Si–OH) are sufficiently accessible to interact strongly with human cell membranes, such as those of the lungs. These interactions can damage cells and trigger an inflammatory response from the immune system. If this inflammation persists due to repeated or prolonged exposures (for instance, among workers exposed to crystalline silica dust), it can lead to chronic diseases such as silicosis as well as autoimmune disorders.
Silica: skin tolerance and dermatological profile.
The skin tolerance of amorphous silica is generally good. In vitro and in vivo studies confirm the absence of irritation, sensitization or cutaneous toxicity. Its mode of action relies solely on physical properties, such as the absorption of sebum, formula texture modification and optical light diffusion. Sensations of dryness or transient discomfort may, however, occur on dry or sensitive skin due to its absorption capacity. When used in a granular (non-spherical) form, silica can also serve as a mechanical mechanical exfoliating agent. In this case, the choice of particle size is crucial to prevent excessive abrasion.
Environmental impact: silica, a sustainable alternative.
From an environmental standpoint, silica has a favorable profile. Unlike the microplastics formerly used as exfoliants (polyethylene, nylon), silica is mineral, non-persistent in aquatic environments, and non-bioaccumulative. It thus represents a sustainable alternative in rinse-off products and eco-friendly formulations.
From an environmental standpoint, silica is a more environmentally friendly option. Unlike microplastics such as polyethylene or nylon, formerly used in scrubs, silica is of mineral origin, meaning it is primarily derived from sand or quartz. It does not linger in water, does not cause lasting pollution in rivers or oceans, and does not accumulate in living organisms. This is why it is considered a greener alternative, particularly in rinse-off products or in treatments designed to minimize their environmental impact.
In summary.
Amorphous forms, spherical or porous, are authorized in cosmetics by the European regulation.
Applied to the skin, silica is not inhaled and does not present any identified hazards.
The inhaled crystalline silica can cause silicosis or cancers after prolonged exposure.
Silica nanoparticles in sprays or aerosols can pose risks if inhaled.
Sources
SANDERSON W. T. & al. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occupational and Environmental medicine (2003).
AVIRAM M. & al. Silicon dioxide nanoparticles increase macrophage atherogenicity: Stimulation of cellular cytotoxicity, oxidative stress, and triglycerides accumulation. Environmental Toxicology (2016).
POLLARD K.M. & al. Silica, Silicosis, and Autoimmunity. Frontiers in Immunology (2016).
FUBINI B. & al. Nearly free surface silanols are the critical molecular moieties that initiate the toxicity of silica particles. Proceedings of the National Academy of Sciences (2020).
HEE LEE J. & al. Skin Sensitization Potential and Cellular ROS-Induced Cytotoxicity of Silica Nanoparticles. Nanomaterials (2021).
MOKRA D. & al. New Insights into Pathomechanisms and Treatment Possibilities for Lung Silicosis. International Journal of Molecular Sciences (2021).
ANDUJAR P. & al. Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review. Nanomaterials (2022).
NOLDE J. & al. Investigation on the skin penetration of synthetic amorphous silica (SAS) used in cosmetic products. Toxicology Letters (2024).
Diagnostic
Understand your skin
and its complex needs.